Showing 81-90 of 7518 results for "".
Allergan's Cool Campaign, Obagi Line Launches, Apple Upgrades Health App
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-allergan-s-cool-campaign-obagi-line-launches-apple-upgrades-health-app/18346/There's some misleading information about fat reduction out there, and that's not cool, Allergan says. The company's CoolSculpting device has launched the “Not Cool Vs. Cool” campaign. Data show patients and doctors assess scars differently: Patients tend to focus on scar depth, while physicians focDermWireTV: Enbrel/AD Link, LGBTQ Health and Dermatology
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-enbrelad-link-lgbtq-health-and-dermatology/19624/Signals in accumulated data for Enbrel seem to suggest that etanercept may have a protective effect against Alzheimer’s disease, the Washington Post reported earlier this month. The AAD position statement on Sexual and Gender Minority Health in Dermatology says that, “Dermatologists can and should cDermWireTV: AbbVie to Acquire Allergan, Duobrii Launches, SDPA at 25
https://practicaldermatology.com/topics/psoriasis/dermwiretv-abbvie-to-acquire-allergan-duobrii-launches-sdpa-at-25/19629/In a deal with an equity value of approximately $63 billion, AbbVie has agreed to acquire Allergan. The new company is positioned for new growth platforms and a diversified revenue base; the deal will be immediately accretive to earnings per share, AbbVie says. The Society of Dermatology Physician AEnhancing Your Procedures with Chemical Peels & Nutraceuticals
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/enhancing-your-procedures-with-chemical-peels-nutraceuticals/20274/Do chemical peels and nutraceuticals have a place in today's aesthetic practice? Yes, say Vivian Bucay, MD and Erin Gilbert, MD, PhD, speaking at Cosmetic Surgery Forum 2016 in Las Vegas. Get their pearls for successful integration. Get more info on Cosmetic Surgery Forum.Approval for Evolus; Remembering Vic Narurkar, MD
https://practicaldermatology.com/topics/practice-management/dermwiretv-approval-for-evolus-remembering-vic-narurkar-md/19553/The FDA has approved Jeuveau, the lead product from Evolus, Inc. David Moatazedi, President and CEO of Evolus, and Michael Jafar, Chief Marketing Officer at Evolus, comment on market potential for the new product.Twenty-eight percent of physicians say the prior authorization process required by healA Growing Armamentarium for Psoriasis: How to Choose the Right Treatment for Each Patient
https://practicaldermatology.com/topics/psoriasis/a-growing-armamentarium-for-psoriasis-how-to-choose-the-right-treatment-for-each-patient/18214/Erin Boh, MD joins host Joshua Zeichner, MD in this edition of DermTube Journal Club to offer tips for navigating all the new and existing treatment options for patients with moderate to severe psoriasis. With so many effective options on the market, Dr. Boh says it's possible to find the best fit fHow Effective is the Liquid Facelift?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/how-effective-is-the-liquid-facelift/18621/Liquid facelifts offer patients a non-surgical approach to creating the same effect as a surgery. Suneel Chilukuri, MD says by combing fillers, neuromodulators, devices, and at-home care, it's possible to tighten, lift, and generate new collagen. He says this non-invasive combination can achieve aboMichael Gold Honored, CSF Highlights, Anxiety Linked to Skin Disease
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-michael-gold-honored-csf-highlights-anxiety-linked-to-skin-disease/18720/From bloodless blephs to nutraceuticals, innovative approaches to patient care take the spotlight at Cosmetic Surgery Forum each year. This year, the meeting introduced new topics and new speakers, says CSF founder and Practical Dermatology Chief Cosmetic Surgery Editor, Dr. Joel Schlessinger. Dr. MGalderma's Future, Allergan's Bonti Buy, and Sebacia Clearance
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-galderma-s-future-allergan-s-bonti-buy-and-sebacia-clearance--xgheloga/18233/Nestle's Board says it has come to the conclusion that the future growth opportunities of Nestlé Skin Health lie increasingly outside the Group's strategic scope and expects a review of strategic options for Nestlé Skin Health to be complete by mid-2019. Allergan is acquiring Bonti for 195 million dAD Impact, Allofill Comes to Market, GPA Launches
https://practicaldermatology.com/topics/psoriasis/dermwiretv-ad-impact-allofill-comes-to-market-gpa-launches/18567/From sleep disruptions or negative impact on the ability to work to feelings of depression and anxiety, atopic dermatitis can have significant effects on adults, new research suggests. In fact, more than half of respondents to a Harris Poll say that AD has negatively impacted their daily lives. Dori